Sign in

FSSAI withdraws order banning ‘A1/A2’ milk ads

The order directed food businesses to stop marketing and selling milk and milk products as A1 and A2 types as these were “misleading claims”.

Updated on: Aug 27, 2024, 05:13:10 IST
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link

New Delhi: Country’s apex food safety regulator — Food Safety and Standards Authority of India (FSSAI) — on Monday withdrew its earlier order asking food businesses to stop marketing and selling milk and milk products as A1 and A2 types as these were “misleading claims”.

Representational Image
Representational Image

Also Read: FSSAI crackdown on ‘A1 or A2’ milk product ads

FSSAI, in an updated directive, said the advisory was withdrawn with immediate effect to carry out further consultations with relevant stakeholders.

“Clarification regarding selling or marketing of milk and milk products such as ghee, butter, curd etc in the name of A1 & A2 types… This is to inform that the advisory dated 21.08.2024 issued with respect to the subject cited, stands withdrawn for further consultation and engagement with the stakeholders,” said the FSSAI order issued on Monday.

In the earlier order curbing what it saw as deceptive promotion, the FSSAI said regulator explained that the A1 and A2 distinction in milk is related to differences in protein structure, specifically beta-casein. It emphasised that current milk standards, as specified in Food Safety and Standards Regulations 2011 did not recognise any differentiation based on A1 and A2 types.

According to people familiar with the matter, the directive was withdrawn as a section of milk business operators feared that the decision to ban marketing under A1&A2 was rushed and it would hurt the market of indigenous milk producers.

  • Rhythma Kaul
    ABOUT THE AUTHOR
    Rhythma Kaul

    Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More